MARKET NEWS

Mustang Bio Licenses LentiBOOST Technology From SIRION Biotech
Gerresheimer Includes Stevanato Group Integrated Twist-Off Closure System Solution for Gx RTF Syringes
Gelest Shareholders Close Sale to Mitsubishi Chemical
Evaxion Biotech Launches New AI Powered Platform to Enable Faster Response to Emerging Viral Pandemics
Catalent Launches OneXpress Solution to Accelerate Oral Dosage Products From Clinic to Launch
AiViva Biopharma Initiates Phase 1/2 Clinical Trial of AIV001 for Nonmelanoma Skin Cancer
Noble & Aptar Pharma Connected Medical Device Solution for Disease Management Adherence & Onboarding Patients

  FEATURED EDITORIAL

  COMPANY PROFILE

 

Foster Delivery Science focuses on GMP and Formulation development Hot Melt Extrusion, applying our expertise using twin screw extruders not only for traditional solubility enhancement techniques, but to create local and long term Drug Delivery Implant and film solutions.  As extrusion is a continuous process by nature, melt granulation programs are an obvious interest for lifecycle management and new drug development. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Proveris Scientific Research Collaboration: New Generation Technologies for Improved Measurement of Pharmaceutical Aerosols

Proveris Scientific Research Collaboration: New Generation Technologies for Improved Measurement of Pharmaceutical Aerosols

Proveris Scientific Corporation recently announced its research collaboration with The University of Sydney and Macquarie University on a project to develop a new generation of technologies for improving….

Recipharm Signs Agreement With Arcturus Therapeutics to Support the Manufacture of LUNAR-COV19 (ARCT-021) Vaccine Candidate

Recipharm Signs Agreement With Arcturus Therapeutics to Support the Manufacture of LUNAR-COV19 (ARCT-021) Vaccine Candidate

Recipharm has recently entered into an agreement with Arcturus Therapeutics, a leading US-based clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and….

First Commercial Drug Manufactured Via Ajinomoto Bio-Pharma Services’ AJIPHASE Technology Receives FDA Approval

First Commercial Drug Manufactured Via Ajinomoto Bio-Pharma Services’ AJIPHASE Technology Receives FDA Approval

Ajinomoto Bio-Pharma Services recently announce the US FDA has approved the first commercial drug manufactured via Aji Bio-Pharma’s proprietary AJIPHASE production process…..

Bristol Myers Squibb to Acquire MyoKardia for .1 Billion

Bristol Myers Squibb to Acquire MyoKardia for $13.1 Billion

Bristol Myers Squibb and MyoKardia, Inc. recently announced a definitive merger agreement under which Bristol Myers Squibb will acquire MyoKardia for $13.1 billion, or….

Evonik Launches New Oral Drug Delivery Technology for Enteric Protection & Rapid Release in the Upper Small Intestine

Evonik Launches New Oral Drug Delivery Technology for Enteric Protection & Rapid Release in the Upper Small Intestine

Evonik has recently launched an advanced oral drug delivery technology that provides enteric protection followed by rapid, homogeneous release for effective….

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

October 21 – Capsules
October 28 – Analytical Testing